Arcadia Biosciences, Inc.
RKDA
$3.60
$0.020.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.52% | 21.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.52% | 21.25% | |||
| Cost of Revenue | 6.12% | 22.14% | |||
| Gross Profit | -32.80% | 20.08% | |||
| SG&A Expenses | -26.05% | 22.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.98% | 22.15% | |||
| Operating Income | 23.25% | -23.03% | |||
| Income Before Tax | 119.20% | -271.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 119.20% | -271.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 119.20% | -271.53% | |||
| EBIT | 23.25% | -23.03% | |||
| EBITDA | 22.61% | -23.12% | |||
| EPS Basic | 119.20% | -271.40% | |||
| Normalized Basic EPS | 115.68% | -742.48% | |||
| EPS Diluted | 119.01% | -271.64% | |||
| Normalized Diluted EPS | 129.73% | -437.74% | |||
| Average Basic Shares Outstanding | 0.01% | 0.07% | |||
| Average Diluted Shares Outstanding | -47.24% | 90.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||